A proteomic atlas of insulin signalling reveals tissue‐specific mechanisms of longevity assurance

A proteomic atlas of insulin signalling reveals tissue‐specific mechanisms of longevity assurance

Abstract Lowered activity of the insulin/IGF signalling (IIS) network can ameliorate the effects of ageing in laboratory animals and, possibly, humans. Although transcriptome remodelling in long‐lived IIS mutants has been extensively documented, the causal mechanisms contributing to extended lifespa...

Full description

Bibliographic Details
Main Authors:	Luke S Tain, Robert Sehlke, Chirag Jain, Manopriya Chokkalingam, Nagarjuna Nagaraj, Paul Essers, Mark Rassner, Sebastian Grönke, Jenny Froelich, Christoph Dieterich, Matthias Mann, Nazif Alic, Andreas Beyer, Linda Partridge
Format:	Article
Language:	English
Published:	Springer Nature 2017-09-01
Series:	Molecular Systems Biology
Subjects:	ageing insulin/IGF mitochondria proteasome proteome
Online Access:	https://doi.org/10.15252/msb.20177663

Similar Items

Tissue-specific modulation of gene expression in response to lowered insulin signalling in Drosophila
by: Luke Stephen Tain, et al.
Published: (2021-04-01)

MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
by: Danielle Yaron-Saminsky, et al.
Published: (2021-11-01)

Molecular characteristics of IGF and IGF1R genes and their potential roles on longevity in two scallops with distinct lifespans
by: Yuan Wang, et al.
Published: (2023-12-01)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
by: Camille Schlesser, et al.
Published: (2022-05-01)

New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies
by: Romina A. Guedes, et al.
Published: (2023-08-01)

Postmortem Degradation of Qinchuan Beef Protein by Proteasome and Its Mediated Ubiquitin-Proteasome Pathway
by: HU Lijun, ZHANG Qian, CHEN Xueyan, WANG Jinxia, LI Rong, LI Yalei, LUO Ruiming
Published: (2023-12-01)

Chronic Administration of Non-Constitutive Proteasome Inhibitor Modulates Long-Term Potentiation and Glutamate Signaling-Related Gene Expression in Murine Hippocampus
by: Alexander Maltsev, et al.
Published: (2023-05-01)

A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes
by: Alexander Burov, et al.
Published: (2021-11-01)

Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01)

The ATP/Mg<sup>2+</sup> Balance Affects the Degradation of Short Fluorogenic Substrates by the 20S Proteasome
by: Alexey Morozov, et al.
Published: (2022-02-01)

Proteasomes in Patient Rectal Cancer and Different Intestine Locations: Where Does Proteasome Pool Change?
by: Pavel A. Erokhov, et al.
Published: (2021-03-01)

IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood: A Systematic Review
by: Justyna Szydlowska-Gladysz, et al.
Published: (2024-04-01)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
by: Stefanie de Groot, et al.
Published: (2020-11-01)

Characterization and expression analysis of gonad specific igf3 in the medaka ovary
by: Jiale Xie, et al.
Published: (2022-05-01)

Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
by: Marta Pelon, et al.
Published: (2024-03-01)

The Ubiquitin–Proteasome System (UPS) and Viral Infection in Plants
by: Dania P. Lobaina, et al.
Published: (2022-09-01)

The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes
by: Ayaka Watanabe, et al.
Published: (2022-05-01)

Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma
by: Francesca Alessandra Ambrosio, et al.
Published: (2023-02-01)

Specific lid-base contacts in the 26s proteasome control the conformational switching required for substrate degradation
by: Eric R Greene, et al.
Published: (2019-11-01)

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
by: Karthik Nagaraj, et al.
Published: (2022-10-01)

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
by: Maria Pascual‐Lucas, et al.
Published: (2014-10-01)

New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations
by: Joseph A.M.J.L. Janssen
Published: (2020-04-01)

The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01)

PA28γ: New Insights on an Ancient Proteasome Activator
by: Paolo Cascio
Published: (2021-02-01)

Immunohistochemical localization of IGF-I, IGF-II and MSTN proteins during development of triploid sea bass (Dicentrarchus labrax)
by: G. Radaelli, et al.
Published: (2010-04-01)

Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy
by: Pierluigi Scalia, et al.
Published: (2023-12-01)

Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
by: Mahdi Pakjoo, et al.
Published: (2024-02-01)

Role of Proteasomes in Inflammation
by: Carl Christoph Goetzke, et al.
Published: (2021-04-01)

Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication
by: Martin Voss, et al.
Published: (2021-07-01)

The C-Terminus of the PSMA3 Proteasome Subunit Preferentially Traps Intrinsically Disordered Proteins for Degradation
by: Assaf Biran, et al.
Published: (2022-10-01)

RETRACTED: Proteasome storage granules protect proteasomes from autophagic degradation upon carbon starvation
by: Richard S Marshall, et al.
Published: (2018-04-01)

The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer
by: Boranai Tychhon, et al.
Published: (2023-07-01)

Therapeutic targeting of cancer cell cycle using proteasome inhibitors
by: Rastogi Namrata, et al.
Published: (2012-12-01)

Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
by: Seokhyun Jin, et al.
Published: (2023-05-01)

Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug
by: Yinhsuan Michely Chen, et al.
Published: (2020-04-01)

Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival
by: Yinhsuan Michely Chen, et al.
Published: (2023-02-01)

IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling
by: Yosuke Yoneyama, et al.
Published: (2018-04-01)

Differing adaptations of IGF-I and its IGFBPs in dairy cows during a negative energy balance in early lactation and a negative energy balance induced by feed restriction in mid-lactation
by: E.C. Kessler, et al.
Published: (2013-09-01)

A cryptic K48 ubiquitin chain binding site on UCH37 is required for its role in proteasomal degradation
by: Jiale Du, et al.
Published: (2022-04-01)

A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression
by: Martina Chrudinová, et al.
Published: (2024-02-01)